ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

POLX Polarean Imaging Plc

3.65
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.65 3.50 3.80 3.65 3.65 3.65 81,192 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.57 7.88M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 3.65p. Over the last year, Polarean Imaging shares have traded in a share price range of 3.65p to 32.25p.

Polarean Imaging currently has 215,848,593 shares in issue. The market capitalisation of Polarean Imaging is £7.88 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -0.57.

Polarean Imaging Share Discussion Threads

Showing 1101 to 1123 of 6500 messages
Chat Pages: Latest  56  55  54  53  52  51  50  49  48  47  46  45  Older
DateSubjectAuthorDiscuss
26/8/2021
08:46
Same trade now displaying again. 86.0 / 86.5 so maybe a roll over?
rhatton
26/8/2021
08:24
Not long until October 5th.
oapknob1
26/8/2021
07:56
It's blue now fwiw
moontheloon
26/8/2021
07:54
As discussed on another site it could well have been worked over several sessions and not legally bound to state when actioned for abnormal trades that big... Common sense and our situation says buy.
moontheloon
26/8/2021
07:49
Red last night now green to show mid. Buy or sell ? Let's see if share price rises or not
oapknob1
25/8/2021
23:02
No idea as I’m long but the market is always showing us there are surprises around the corner so to be aware that things might not pan out as expected.

If that was a buy I would imagine the price would really driven higher but I might be wrong. Let’s see what tomorrow brings

rhatton
25/8/2021
22:32
What would lead to a ‘nay’?
wetdream
25/8/2021
21:11
Someone was happy to dump them.
Agree, why sell now?

wetdream
25/8/2021
20:58
And why would you sell at this stage...
moontheloon
25/8/2021
20:35
Looks like a buy, such a large trade would take a long time to fill and the share price has gone up in the last few trading sessions.
quemaster
25/8/2021
20:31
More than likely a buy... From before tick up?
moontheloon
25/8/2021
20:11
Delayed or not delayed ?
oapknob1
25/8/2021
18:35
1.1m ‘sell’ after the close.
Really?

wetdream
25/8/2021
10:41
Starting to see the sells coming through that have soaked up the steady buying in recent days.
wetdream
25/8/2021
10:33
Let's hope so log
moontheloon
25/8/2021
08:27
That's when it is due but I suppose delays are possible. No hint of delays so far and its possible for the result to come early.
loglorry1
25/8/2021
07:54
Is the 5th latest results day to be expect them by? Can't help thinking going to be stretched but don't know the efficiency of fda
moontheloon
24/8/2021
14:48
41 days and 16 hours to go for FDA result!
loglorry1
24/8/2021
13:26
If we believe the trades descriptions, then there must be a seller in the background to soak up what appears to be near 100% buys.
wetdream
23/8/2021
08:47
92p stateside ?
oapknob1
22/8/2021
22:15
The Nasdaq ADS shares are 2:1 to the LSE shares.
goldeast
22/8/2021
21:27
‘…with a buy rating and a price Target of $38, equivalent to £14 per share.’

So, 2.7USD to the £STG…?

Er…that doesn’t look right.

wetdream
22/8/2021
12:38
I was hoping for 26 August, but a knowledgeable poster, Wan, concluded a recent post with, . There is plenty of headroom in terms of the share price target with Berenberg analyst Anita Dushyanth recently initiating coverage on Renalytix (NASDAQ:RNLX) with a buy rating and a price Target of $38, equivalent to £14 per share. Hopefully, we will get the news flow that further supports that type of valuation (and beyond!) 'post' August.....Roll on September!
goldeast
Chat Pages: Latest  56  55  54  53  52  51  50  49  48  47  46  45  Older

Your Recent History

Delayed Upgrade Clock